MMedication Read More GLP-1 drugs reshape alcohol consumption and hospitality habitsApril 2, 2026 Millions of Britons using GLP-1 weight loss medications are beginning to alter how they drink, dine and choose…
MMedication Read More FDA Approves Eli Lilly’s GLP-1 PillApril 2, 2026 The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily,…
MMedication Read More Black Country patients urged to order medication ahead of Easter – BBCApril 2, 2026 Black Country patients urged to order medication ahead of Easter BBCBoots pharmacist reveals the ideal date to order prescriptions…
MMedication Read More All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weightApril 2, 2026 G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
MMedication Read More FDA Recalls Nearly 90,000 Bottles of Children’s Ibuprofen Due to ‘Foreign Substance’April 2, 2026 The U.S. Food and Drug Administration has announced that nearly 90,000 bottles of children’s ibuprofen sold nationwide have…
MMedication Read More Free Market Ozempic Will Make a Huge Difference to Tens of Millions of PeopleApril 1, 2026 Photo by David Trinks The New York Times had an interesting piece on the implications of Ozempic becoming…
MMedication Read More New Wegovy subscription program could save patients $1,200 a year – NBC 5 Dallas-Fort WorthApril 1, 2026 The maker of the GLP-1 weight-loss drug Wegovy is promising “a lower, predictable monthly price” for patients who…
MMedication Read More List of Medications That Could Disqualify You From DrivingApril 1, 2026 Following news that Tiger Woods was carrying two hydrocodone pills—which are commonly prescribed for pain—when he was interviewed…
MMedication Read More Kerry pharmacist welcomes medicine blister packs agreementApril 1, 2026 A Kerry pharmacist has welcomed the agreement reached on medicine blister packs. The HSE and the Irish Pharmacy…
MMedication Read More PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT DataApril 1, 2026 – PGN-EDODM1 was generally well-tolerated with all adverse events mild or moderate and no serious adverse events reported…
MMedication Read More FDA approves GLP-1 weight loss pill Foundayo from Eli LillyApril 1, 2026 The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe…
MMedication Read More Digant Sharma and Vibha Jain Launch Hypnotherapy Private LimitedApril 1, 2026 SMPL Mumbai (Maharashtra) [India], April 1: In a significant development for India’s mental wellness and holistic healing landscape,…